Congress aims to encourage generic alternatives to brand-name medicines
Millions of Americans take prescription drugs to feel better, but the prices they pay often keep them feeling a bit sick. Dyazide, a brand-name drug for the treatment of high blood pressure, costs as much as $21.50 for 100 capsules. The drug racked up sales of $230 million last year for its manufacturer, Smith Kline & French. Although the company's patent on the drug expired in 1980, no other firm has come out with a less expensive version. Dyazide is just one of many bestselling...
To continue reading:
or
Log-In
